N-ethyl-n-[3-(1-methyltetrazol-5-yl)sulfanylpropyl]cyclopentanecarboxamide (CED0241411)

Record Information
Version1.0
Creation Date2026-08-28 03:16:11 UTC
Update Date2026-08-28 03:16:11 UTC
SynCED IDCED0241411
Secondary Accession Numbers
  • CHEM285621
Identification
Common NameN-ethyl-n-[3-(1-methyltetrazol-5-yl)sulfanylpropyl]cyclopentanecarboxamide
ClassSmall Molecule
Description
N-ethyl-n-[3-(1-methyltetrazol-5-yl)sulfanylpropyl]cyclopentanecarboxamide belongs to the aryl thioethers, a subclass of thioethers within the organic compounds. It has the chemical formula C13H23N5OS and an average molecular weight of 297.42 g/mol. This compound is further classified as part of the organosulfur compounds superclass.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC13H23N5OS
Average Molecular MassNot Available
Monoisotopic Mass297.162 g/mol
CAS Registry Number80085-45-6
IUPAC NameNot Available
Traditional NameNot Available
SMILESCCN(CCCSC1=NN=NN1C)C(=O)C2CCCC2
InChI IdentifierInChI=1S/C13H23N5OS/c1-3-18(12(19)11-7-4-5-8-11)9-6-10-20-13-14-15-16-17(13)2/h11H,3-10H2,1-2H3
InChI KeyILQSPLOAWFZQTB-UHFFFAOYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
769.0 Log mg/kg [430:1400]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
Exposure Sources
Source IDSourceSectorReference
CEDs000530Radio Transmission Systems?Radio transmission systems utilize a variety of synthetic chemicals in their manufacturing and maintenance processes.Electrical & Electronic EquipmentPubChem
Pathways
0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
5-hydroxytryptamine receptor 1A structureClick to view 3D structure5-hydroxytryptamine receptor 1AP08908HumansPredicted (SEA)
Prediction Confidence Score
0.244
Applicability Domain
0.253 Low confidence
Statistical Significance
0.3224
Supporting Reference Compounds
953
E-value
2509.78
Alpha-1A adrenergic receptor structureClick to view 3D structureAlpha-1A adrenergic receptorP35348HumansPredicted (SEA)
Prediction Confidence Score
0.242
Applicability Domain
0.253 Low confidence
Statistical Significance
0.185
Supporting Reference Compounds
376
E-value
1440.6
D(4) dopamine receptor structureClick to view 3D structureD(4) dopamine receptorP21917HumansPredicted (SEA)
Prediction Confidence Score
0.234
Applicability Domain
0.253 Low confidence
Statistical Significance
0.3198
Supporting Reference Compounds
524
E-value
2489.38
5-hydroxytryptamine receptor 7 structureClick to view 3D structure5-hydroxytryptamine receptor 7P34969HumansPredicted (SEA)
Prediction Confidence Score
0.232
Applicability Domain
0.253 Low confidence
Statistical Significance
0.3241
Supporting Reference Compounds
565
E-value
2523.33
Click to view 3D structure5-hydroxytryptamine receptor 1AP19327Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.227
Applicability Domain
0.253 Low confidence
Statistical Significance
0.356
Supporting Reference Compounds
541
E-value
2771.2
Click to view 3D structureAlpha-1B adrenergic receptorP35368HumansPredicted (SEA)
Prediction Confidence Score
0.226
Applicability Domain
0.253 Low confidence
Statistical Significance
0.2592
Supporting Reference Compounds
298
E-value
2017.62
5-hydroxytryptamine receptor 2A structureClick to view 3D structure5-hydroxytryptamine receptor 2AP28223HumansPredicted (SEA)
Prediction Confidence Score
0.225
Applicability Domain
0.247 Low confidence
Statistical Significance
0.5609
Supporting Reference Compounds
955
E-value
4366.95
Cyclin-dependent kinase 2 structureClick to view 3D structureCyclin-dependent kinase 2P24941HumansPredicted (SEA)
Prediction Confidence Score
0.223
Applicability Domain
0.241 Low confidence
Statistical Significance
0.6425
Supporting Reference Compounds
1029
E-value
5001.73
Aurora kinase B structureClick to view 3D structureAurora kinase BQ96GD4HumansPredicted (SEA)
Prediction Confidence Score
0.223
Applicability Domain
0.241 Low confidence
Statistical Significance
0.6463
Supporting Reference Compounds
1017
E-value
5031.47
MAP/microtubule affinity-regulating kinase 3 structureClick to view 3D structureMAP/microtubule affinity-regulating kinase 3P27448HumansPredicted (SEA)
Prediction Confidence Score
0.222
Applicability Domain
0.241 Low confidence
Statistical Significance
0.5593
Supporting Reference Compounds
627
E-value
4354.5
Vascular endothelial growth factor receptor 2 structureClick to view 3D structureVascular endothelial growth factor receptor 2P35968HumansPredicted (SEA)
Prediction Confidence Score
0.221
Applicability Domain
0.241 Low confidence
Statistical Significance
0.7351
Supporting Reference Compounds
1660
E-value
5722.77
Tyrosine-protein kinase JAK2 structureClick to view 3D structureTyrosine-protein kinase JAK2O60674HumansPredicted (SEA)
Prediction Confidence Score
0.219
Applicability Domain
0.241 Low confidence
Statistical Significance
0.6937
Supporting Reference Compounds
1022
E-value
5400.4
Click to view 3D structureNeuropeptide S receptorP0C0L6Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.218
Applicability Domain
0.218 Low confidence
Statistical Significance
0.0118
Supporting Reference Compounds
1
E-value
91.5507
Tyrosine-protein kinase Lyn structureClick to view 3D structureTyrosine-protein kinase LynP07948HumansPredicted (SEA)
Prediction Confidence Score
0.218
Applicability Domain
0.241 Low confidence
Statistical Significance
0.6118
Supporting Reference Compounds
666
E-value
4762.5
Voltage-gated inwardly rectifying potassium channel KCNH2 structureClick to view 3D structureVoltage-gated inwardly rectifying potassium channel KCNH2Q12809HumansPredicted (SEA)
Prediction Confidence Score
0.218
Applicability Domain
0.224 Low confidence
Statistical Significance
0.8614
Supporting Reference Compounds
1498
E-value
6706.17
Hepatocyte growth factor receptor structureClick to view 3D structureHepatocyte growth factor receptorP08581HumansPredicted (SEA)
Prediction Confidence Score
0.218
Applicability Domain
0.241 Low confidence
Statistical Significance
0.6812
Supporting Reference Compounds
934
E-value
5303.17
Ephrin type-A receptor 2 structureClick to view 3D structureEphrin type-A receptor 2P29317HumansPredicted (SEA)
Prediction Confidence Score
0.218
Applicability Domain
0.241 Low confidence
Statistical Significance
0.6101
Supporting Reference Compounds
611
E-value
4749.97
Epidermal growth factor receptor structureClick to view 3D structureEpidermal growth factor receptorP00533HumansPredicted (SEA)
Prediction Confidence Score
0.217
Applicability Domain
0.241 Low confidence
Statistical Significance
0.7516
Supporting Reference Compounds
1301
E-value
5851.15
Tyrosine-protein kinase ITK/TSK structureClick to view 3D structureTyrosine-protein kinase ITK/TSKQ08881HumansPredicted (SEA)
Prediction Confidence Score
0.217
Applicability Domain
0.241 Low confidence
Statistical Significance
0.5844
Supporting Reference Compounds
570
E-value
4549.35
Fibroblast growth factor receptor 3 structureClick to view 3D structureFibroblast growth factor receptor 3P22607HumansPredicted (SEA)
Prediction Confidence Score
0.217
Applicability Domain
0.241 Low confidence
Statistical Significance
0.5997
Supporting Reference Compounds
616
E-value
4668.54
Aurora kinase A structureClick to view 3D structureAurora kinase AO14965HumansPredicted (SEA)
Prediction Confidence Score
0.214
Applicability Domain
0.241 Low confidence
Statistical Significance
0.72
Supporting Reference Compounds
996
E-value
5604.83
5-hydroxytryptamine receptor 2B structureClick to view 3D structure5-hydroxytryptamine receptor 2BP41595HumansPredicted (SEA)
Prediction Confidence Score
0.214
Applicability Domain
0.247 Low confidence
Statistical Significance
0.6452
Supporting Reference Compounds
686
E-value
5022.75
D(2) dopamine receptor structureClick to view 3D structureD(2) dopamine receptorP14416HumansPredicted (SEA)
Prediction Confidence Score
0.214
Applicability Domain
0.224 Low confidence
Statistical Significance
0.6875
Supporting Reference Compounds
1103
E-value
5352.37
Tyrosine-protein kinase JAK3 structureClick to view 3D structureTyrosine-protein kinase JAK3P52333HumansPredicted (SEA)
Prediction Confidence Score
0.213
Applicability Domain
0.241 Low confidence
Statistical Significance
0.7343
Supporting Reference Compounds
961
E-value
5716.31
Non-receptor tyrosine-protein kinase TYK2 structureClick to view 3D structureNon-receptor tyrosine-protein kinase TYK2P29597HumansPredicted (SEA)
Prediction Confidence Score
0.213
Applicability Domain
0.241 Low confidence
Statistical Significance
0.665
Supporting Reference Compounds
657
E-value
5177.36
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available